Trim 20% of SPCX at $150-152; front-load execution, tighten stop to $140, retain 1.5-2.0% core
The Underweight rating is supported by a confluence of headwinds: stretched valuation (97.6x forward P/E), negative FCF (-$16.8B/quarter), hawkish macro backdrop (90% 2026 rate hike probability), and ongoing lockup supply pressure. The 20% trim magnitude is binding per validated lessons (9/04 SPCX reflection, 9/08 and 9/09 Underweight decisions), calibrated at the high end of the 15-20% range given the more stretched current setup versus prior decisions. Full exit or 40-50%+/60-70%/100% trims are rejected as alpha-destructive per 8/25-8/26 pattern recognition. Execution is front-loaded at $150-152 rather than staged into $154-156 double-top resistance per NFLX 9/03 cross-ticker reflection. Stop tightened to $140 (below 200 SMA at ~$142) from trader's $135, acknowledging institutional floor defense at $108-130 zone. Core retention of 1.5-2.0% preserves asymmetric upside participation given validated operational inflection (Q2 revenue +92% YoY, gross margin 55.3%, OCF +$2.42B) and institutional ownership floor (Nvidia, Harvard, Alphabet).
| Position | Action |
|---|---|
| Valuation stretched (97.6x forward P/E), negative FCF (-$16.8B/quarter), hawkish macro (90% hike probability 2026), lockup supply pressure | Trim 20% of position |
| Current allocation 2-3% | Reduce to ~1.5-2.0% portfolio allocation |
| Maintain core exposure for asymmetric upside participation | Retain 1.5-2.0% core (not 0.5-1% or zero) |
| Execution sequencing at resistance zone $154-156 | Override: front-load at $150-152 instead of staging into resistance |
SPCX presents an asymmetric catalyst-driven opportunity centered on Starship Flight 14 transitioning from R&D to revenue-generating asset, supported by staggering fundamentals (92% YoY revenue growth, 55.3% gross margins, positive operating cash flow) and favorable risk/reward of 2:1 to 3:1 to the upside.
| Indicator | Value | Signal |
|---|---|---|
| Close | 151.21 | bullish |
| 10 EMA | 146.84 | neutral |
| 50 SMA | 135.07 | neutral |
| 200 SMA | 142.21 | neutral |
| RSI | 59.22 | bullish |
| MACD | 4.34 | bullish |
| MACD Signal | 3.57 | bullish |
| MACD Histogram | +0.77 | bullish |
| Bollinger Middle (20 SMA) | 142.99 | neutral |
| Bollinger Upper | 153.82 | neutral |
| Bollinger Lower | 132.17 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: FCF improvement on Q3 print
Then: Reassess for potential increase
The $13B AI compute deal represents validation, not a 'priced-in' event, with institutional accumulation evident in technicals
EV: +23-36% ($186-206 from $151.21) · concedes: Starship failure or major delay (40% × -$30 = -$12); Macro shock (20% × -$20 = -$4); Lockup cascade (15% × -$15 = -$2); Bear case expected value: -$18/share = -12% downside to ~$133
SPCX is structurally sound but priced for perfect execution in an environment of tightening financial conditions, persistent supply overhang from the lockup calendar, rising competitive threats, and a rate-sensitive valuation that leaves no room for delay or disappointment.
EV: -$18.75/share (-12.4%) · concedes: Successful Flight 14 + chopstick catch = stock rips to $180-200, bull thesis vindicated; Major defense contract expansion = multiple expansion to 110x+ on confirmed recurring revenue; Anthropic IPO complements rather than competes with SpaceX = Musk-ecosystem premium expands; Starship Flight 14 success with payload deployment (regardless of catch); Next lockup release absorbed with <2% drawdown; Macro Fed pivot to dovish (10Y yield back below 4.3%); Q3 earnings beat with FCF improvement or capex guidance reduction
→ vs conservative: Conservative thesis anchors to $220 price target requiring Starship reusability, but Polymarket shows only 4% probability for the specific chopsticks catch milestone the target depends on, and 37% probability for full reusability (down 2.5 points in one week)—holding through a 4% binary event is not risk management, it's hope
→ vs neutral: Neutral 'wait for confirmation' stance is the most expensive option: sitting in a 97.6x P/E name with negative $16 billion quarterly free cash flow while Fed rate hike probability jumped 18 percentage points to 90% means the discount rate on long-duration growth cash flows is repricing higher every session, and 90x-plus multiples have no buffer left against hawkish repricing
| ATR | 7.67 | neutral |
| VWMA | 145.04 | bullish |
Support: 146.84 · 135.07 · 142.99 · 132.17 | Resistance: 153.82 · 154 · 170 · 176
The technical setup is constructive but unconfirmed — momentum indicators (RSI 59.22, MACD bullish cross with +0.77 histogram) and trend structure (price above all MAs) support further upside, but the inability to clear the upper Bollinger Band at 153.82 and the 154.00 trigger level keeps the position from being actionable. A decisive close above 154.00 on volume >90M would confirm the setup targeting 170–176, while a daily close below both VWMA (145.04) and 10 EMA (146.84) would invalidate the thesis. Given ~5.1% daily ATR, position sizing should remain conservative with ATR-based stops (suggested 1.5× ATR ≈ 11.50 below entry).
Market Cap
$1,993.22 B
Share Price (50-day avg)
$135.20
Share Price (200-day avg)
$142.07
52-Week High
$225.64
52-Week Low
$104.83
Forward P/E
97.56
P/B
15.66
EPS (TTM)
-$1.10
Forward EPS
$1.55
Book Value/Share
$9.66
Revenue 2025-Q1
$4,067 M
Revenue 2025-Q2
$4,071 M
Revenue 2026-Q1
$4,694 M
Revenue 2026-Q2
$7,814 M
Gross Profit 2025-Q1
$2,105 M
Gross Profit 2025-Q2
$1,789 M
Gross Profit 2026-Q1
$2,306 M
Gross Profit 2026-Q2
$4,319 M
Gross Margin 2025-Q1
51.8%
Gross Margin 2025-Q2
43.9%
Gross Margin 2026-Q1
49.1%
Gross Margin 2026-Q2
55.3%
Operating Income 2025-Q1
$55 M
Operating Income 2025-Q2
-$775 M
Operating Income 2026-Q1
-$1,954 M
Operating Income 2026-Q2
-$141 M
Net Income 2025-Q1
-$528 M
Net Income 2025-Q2
-$1,008 M
Net Income 2026-Q1
-$4,276 M
Net Income 2026-Q2
-$541 M
Diluted EPS 2025-Q1
-$0.050
Diluted EPS 2025-Q2
-$0.340
Diluted EPS 2026-Q1
-$0.410
Diluted EPS 2026-Q2
-$0.090
R&D Q2 2026
$3,548 M
SG&A Q2 2026
$912 M
Net Interest Expense Q2 2026
-$289 M
Cash & ST Investments Q2 2026
$100,009 M
Cash & ST Investments Q1 2026
$23,675 M
Total Current Assets Q2 2026
$108,047 M
Total Current Assets Q1 2026
$29,732 M
Total Non-Current Assets Q2 2026
$84,702 M
Total Non-Current Assets Q1 2026
$72,343 M
Total Assets Q2 2026
$192,770 M
Total Assets Q1 2026
$102,094 M
Total Current Liabilities Q2 2026
$21,122 M
Total Current Liabilities Q1 2026
$24,436 M
Long-Term Debt Q2 2026
$36,839 M
Long-Term Debt Q1 2026
$28,727 M
Total Debt Q2 2026
$39,708 M
Total Debt Q1 2026
$30,603 M
Total Liabilities Q2 2026
$65,546 M
Total Liabilities Q1 2026
$60,512 M
Common Stock Equity Q2 2026
$127,224 M
Common Stock Equity Q1 2026
$34,533 M
Total Equity Q2 2026
$127,224 M
Total Equity Q1 2026
$41,582 M
Working Capital Q2 2026
$86,925 M
Working Capital Q1 2026
$5,296 M
Current Ratio Q2 2026
5.12
Current Ratio Q1 2026
1.22
Debt/Equity Q2 2026
31.21
Operating Cash Flow Q2 2026
$2,419 M
Operating Cash Flow Q2 2025
-$376 M
CapEx Q2 2026
-$19,238 M
CapEx Q1 2026
-$10,114 M
CapEx Q2 2025
-$2,847 M
Free Cash Flow Q2 2026
-$16,819 M
Free Cash Flow Q1 2026
-$9,067 M
Free Cash Flow Q2 2025
-$3,223 M
Debt Issuance Q2 2026
$29,118 M
Debt Issuance Q1 2026
$22,694 M
Debt Repayment Q2 2026
-$21,192 M
Debt Repayment Q1 2026
-$18,377 M
Stock Issuance Q2 2026
$85,675 M
Stock Issuance Q1 2026
$8,319 M
Stock Issuance Q2 2025
$4,148 M
Financing Cash Flow Q2 2026
$93,166 M
End Cash Position Q2 2026
$94,352 M
End Cash Position Q1 2026
$16,608 M
End Cash Position Q2 2025
$15,094 M
Revenue TTM
$23,044 M
Gross Profit TTM
$11,954 M
EBITDA TTM
$5,897 M
Net Income TTM
-$8,889 M
Operating Margin TTM
-1.80%
Profit Margin TTM
-35.66%
Revenue Growth Q2 YoY
+92%
Goodwill & Intangibles Q2 2026
$14.04 B
PP&E Net Q2 2026
$66.9 B
Construction-in-Progress Q2 2026
$12.6 B
Receivables Q2 2026
$4.35 B
Receivables Q1 2026
$2.8 B
Deferred Revenue Q2 2026
$14.3 B
Current Deferred Revenue Q2 2026
$8.0 B
Long-term Deferred Revenue Q2 2026
$6.3 B
Normalized EBITDA Q2 2026
$2,961 M
D&A Q2 2026
$2.85 B
D&A Q2 2025
$1.53 B
Net Long-term Debt Issuance Q2 2026
$7.9 B
Stockholders Equity Raised Q2 2026
$85.7 B
Strengths
Concerns
SPCX is a high-growth aerospace and defense company in a major capital-build phase, with Q2 2026 revenue of $7.81B representing 92% YoY growth and gross margins expanding to 55.3%. The company raised $85.7B in equity during Q2 2026, ending with $100B in cash and a fortress balance sheet (current ratio 5.12x), though it continues to burn cash with FCF of -$16.8B due to massive $19.2B quarterly capex for Starship and Starlink buildout. The market is pricing in a profitability inflection with forward EPS of $1.55, and while the stock trades 40% below its 52-week high, the key catalyst to watch is whether operating cash flow continues expanding and capex moderates in coming quarters.
Macro: Hawkish shift: 90% Fed rate hike probability in 2026 (+18pp week-over-week). 10Y Treasury yield holding below 5%. Gold rebounding toward $4,350. August CPI firm. Low US recession risk at 7%.